KEY FEATURES
| Full Name | Neuropeptide S |
|---|---|
| Synonym | NP-S |
| Assay Type | Competitive |
| Reactivity | Human |
| Range | 12.35-1000pg/mL |
| Sensitivity | 4.43pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 50μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human NPS in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Competitive-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with Human NPS. During the reaction, Human NPS in the sample or standard competes with a fixed amount of Human NPS on the solid phase supporter for sites on the Biotinylated Detection Ab specific to Human NPS. Excess conjugate and unbound sample or standard are washed away, and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns from blue to yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of Human NPS in tested samples can be calculated by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human NPS ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 47.13 | 94.33 | 352.1 | 48.47 | 96.21 | 333 |
| Standard deviation | 2.37 | 4.88 | 15.25 | 2.85 | 4.77 | 15.25 |
| CV(%) | 5.02 | 5.17 | 4.33 | 5.88 | 4.96 | 4.58 |
RECOVERY
The recovery of Human NPS spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 84-96 | 91 |
| EDTA plasma (n=8) | 90-104 | 96 |
| Cell culture media (n=8) | 93-107 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human NPS in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with NPS ELISA Kits
| NPSR1 ELISA Kit | publications with NPS and NPSR1 |
| NTS ELISA Kit | publications with NPS and NTS |
| POMC ELISA Kit | publications with NPS and POMC |
| ADM ELISA Kit | publications with NPS and ADM |
| OXTR ELISA Kit | publications with NPS and OXTR |
| ADRB1 ELISA Kit | publications with NPS and ADRB1 |
Pathways associated with NPS ELISA Kit
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway | Defective ACTH Causes Obesity And Pro-opiomelanocortinin Deficiency (POMCD) Pathway |
| Disease Pathway | Disease Pathway |
| G Alpha (q) Signalling Events Pathway | G Alpha (q) Signalling Events Pathway |
| G Alpha (s) Signalling Events Pathway | G Alpha (s) Signalling Events Pathway |
| GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
| GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
| Gastrin-CREB Signalling Pathway Via PKC And MAPK | Gastrin-CREB Signalling Pathway Via PKC And MAPK |
| Metabolic Disorders Of Biological Oxidation Enzymes Pathway | Metabolic Disorders Of Biological Oxidation Enzymes Pathway |
| Peptide Ligand-binding Receptors Pathway | Peptide Ligand-binding Receptors Pathway |
Diseases associated with NPS ELISA Kit
| Nervous System Diseases | publications with NPS and Nervous System Diseases |
| Brain Diseases | publications with NPS and Brain Diseases |
| Mental Disorders | publications with NPS and Mental Disorders |
| Neurodegenerative Diseases | publications with NPS and Neurodegenerative Diseases |
| Anxiety Disorders | publications with NPS and Anxiety Disorders |
| Weight Loss | publications with NPS and Weight Loss |
| Trauma, Nervous System | publications with NPS and Trauma, Nervous System |
| Poisoning | publications with NPS and Poisoning |
| Memory Disorders | publications with NPS and Memory Disorders |
| Brain Ischemia | publications with NPS and Brain Ischemia |
